Total Payments
$44,237
2024 Payments
$23,807
Companies
27
Transactions
556
Medicare Patients
11,252
Medicare Billing
$2.2M
Payment Breakdown by Category
Other$29,117 (65.8%)
Food & Beverage$12,447 (28.1%)
Consulting$2,268 (5.1%)
Education$275.20 (0.6%)
Travel$129.18 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $29,117 | 13 | 65.8% |
| Food and Beverage | $12,447 | 534 | 28.1% |
| Consulting Fee | $2,268 | 2 | 5.1% |
| Education | $275.20 | 4 | 0.6% |
| Travel and Lodging | $129.18 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $18,855 | 53 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $15,301 | 39 | $0 (2024) |
| ABBVIE INC. | $2,428 | 113 | $0 (2024) |
| Lilly USA, LLC | $1,301 | 60 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $985.91 | 50 | $0 (2024) |
| Incyte Corporation | $671.23 | 32 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $622.55 | 29 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $497.71 | 24 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $487.78 | 34 | $0 (2024) |
| Janssen Biotech, Inc. | $435.88 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23,807 | 218 | GENZYME CORPORATION ($10,468) |
| 2023 | $16,448 | 180 | GENZYME CORPORATION ($8,125) |
| 2022 | $2,653 | 105 | ABBVIE INC. ($615.55) |
| 2021 | $970.96 | 49 | AbbVie Inc. ($451.09) |
| 2020 | $82.87 | 2 | VYNE Pharmaceuticals Inc. ($60.55) |
| 2019 | $274.28 | 2 | AbbVie, Inc. ($143.28) |
All Payment Transactions
556 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Dermatology | ||||||
| 12/23/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: Dermatology | ||||||
| 12/19/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $19.83 | General |
| 12/18/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Dermatology | ||||||
| 12/16/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $32.82 | General |
| Category: Immunology | ||||||
| 12/16/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Dermatology | ||||||
| 12/14/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.35 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.38 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Immunology | ||||||
| 12/10/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $26.87 | General |
| Category: DERMATOLOGY | ||||||
| 12/06/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $27.76 | General |
| Category: Immunology | ||||||
| 11/26/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: Dermatology | ||||||
| 11/22/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: Dermatology | ||||||
| 11/22/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.66 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $34.04 | General |
| Category: Immunology | ||||||
| 11/18/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Inflammation & Immunology | ||||||
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.44 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,838.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Dermatology | ||||||
| 11/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | SILIQ (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.57 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 4,375 | 14,703 | $2.4M | $1.1M |
| 2022 | 29 | 3,896 | 10,583 | $1.7M | $726,965 |
| 2021 | 28 | 2,653 | 4,523 | $872,864 | $303,846 |
| 2020 | 10 | 328 | 464 | $76,611 | $27,293 |
Total Patients
11,252
Total Services
30,273
Medicare Billing
$2.2M
Procedure Codes
102
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3245 | Injection, tildrakizumab, 1 mg | Office | 2023 | 26 | 5,900 | $986,067 | $649,830 | 65.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,069 | 1,906 | $413,297 | $146,427 | 35.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 399 | 478 | $139,997 | $51,760 | 37.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 415 | 526 | $141,084 | $45,918 | 32.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 596 | 887 | $146,568 | $41,727 | 28.5% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 94 | 102 | $79,576 | $30,662 | 38.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 439 | 2,928 | $49,542 | $19,909 | 40.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 204 | 204 | $54,080 | $18,256 | 33.8% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 84 | 102 | $45,623 | $16,767 | 36.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 81 | 126 | $38,611 | $14,208 | 36.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 196 | 261 | $35,449 | $13,737 | 38.8% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 77 | 83 | $51,389 | $10,309 | 20.1% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 115 | 163 | $21,946 | $8,300 | 37.8% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 27 | 27 | $18,147 | $7,078 | 39.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 34 | 38 | $15,877 | $6,301 | 39.7% |
| 12041 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.5 cm or less | Office | 2023 | 15 | 15 | $10,088 | $3,690 | 36.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 91 | 268 | $9,225 | $3,616 | 39.2% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 19 | 19 | $8,940 | $3,534 | 39.5% |
| 10060 | Simple or single drainage of skin abscess | Office | 2023 | 28 | 29 | $8,885 | $3,415 | 38.4% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 13 | 13 | $10,149 | $3,377 | 33.3% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 21 | 23 | $7,687 | $2,862 | 37.2% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 14 | 14 | $7,149 | $2,806 | 39.2% |
| 96405 | Administration of chemotherapy into growth, 1-7 | Office | 2023 | 11 | 35 | $7,743 | $2,687 | 34.7% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 24 | 28 | $10,474 | $2,647 | 25.3% |
| 11622 | Removal of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 19 | 19 | $12,111 | $2,557 | 21.1% |
About Dr. John Call, MD
Dr. John Call, MD is a Dermatology healthcare provider based in San Ramon, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/21/2016. The National Provider Identifier (NPI) number assigned to this provider is 1376997767.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Call, MD has received a total of $44,237 in payments from pharmaceutical and medical device companies, with $23,807 received in 2024. These payments were reported across 556 transactions from 27 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($29,117).
As a Medicare-enrolled provider, Call has provided services to 11,252 Medicare beneficiaries, totaling 30,273 services with total Medicare billing of $2.2M. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location San Ramon, CA
- Active Since 04/21/2016
- Last Updated 07/09/2022
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1376997767
Products in Payments
- DUPIXENT (Biological) $34,012
- SKYRIZI (Biological) $1,458
- TALTZ (Drug) $1,151
- OPZELURA (Drug) $671.23
- ILUMYA (Biological) $580.14
- Otezla (Drug) $457.65
- SILIQ (Drug) $416.19
- RINVOQ (Biological) $404.30
- HUMIRA (Biological) $404.16
- Sotyktu (Drug) $393.91
- COSENTYX (Drug) $384.92
- Zoryve (Drug) $340.35
- TREMFYA (Drug) $327.46
- VTAMA (Drug) $315.03
- Cimzia (Drug) $250.09
- Ilumya (Biological) $176.90
- Bimzelx (Biological) $167.61
- SPEVIGO (Drug) $159.64
- COSENTYX (Biological) $144.21
- Skyrizi (Biological) $143.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.